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Endovascular stent-grafting of the traumatic thoracic
aortic rupture constitutes an alternative treatment option to
conventional surgical repair. The advantages of endovascular
treatment over conventional surgical repair include the
avoidance of thoracotomy (in the majority of patients),
cardiopulmonary bypass and related complications (SIRS,
ARDS), systemic heparinization complications, ischemia of
spinal cord during aortic cross-clamping, and finally distal
arterial ischemia [1]. While, endovascular treatment seems
to have an advantage over conventional surgical repair
concerning early results, this technique has in our opinion,
two major drawbacks: (A) its superiority concerning early
results is not as significant as reported, and (B) its late results
still remain unknown and may be underestimated. In fact,
reading this excellent study [1] and several others [2,3] we
could note the following: (A1) Although the mortality is
higher in the surgical group in comparison to the stenting
group (21.2% vs 7.7%), this difference is not statistically
significant. (A2) Concerning the incidence of paraplegia there
were no statistically significant differences between two
groups. In addition, the reported two cases of paraplegia
were not related to the surgical procedure itself. (A3) The
accidental occlusion of left subclavian artery, reported in a
high percentage (51%) of stented patients, constitutes a
serious complication, especially for young patients such as
those in this study (average age = 36 years) [1]. However, it
should be noted the fact that the majority of patients were
young, consequently this complication becomes much more
meaningful as it is related to the future professional return,
and the potential use of IMA. Indeed, 25% of the patients with
the above complication had ischemic complications of the
arm and underwent re-operation with low heparinization.
Moreover, it would be interesting for us to have clarification if
the two patients with the late neurological problem belong to
the subgroup with the accidental occlusion of the LSA. (A4)
Conversion to conventional surgery was needed in three
cases.
(B1) The mean follow-up time was significantly shorter in
the endovascular stent-graft group compared to surgical
group: 2.2 years vs 6 years, a fact that will no doubt influence
positively the late results of the endovascular stent-graft
technique. (B2) The quality of the follow-up was greatly
different in the two groups: only 25% of patients belonged to
endovascular stent-graft group evaluated with CT-scan. As a
consequence, further complications of this group may not
have been reported. The reported two deaths in following 18
months due to late sequelae or severe cerebrospinal traumamight be related to the stent technique. In conclusion,
endovascular stent technique in unstable patients with
polytrauma and simultaneous craniocerebral trauma attenu-
ates the surgeon’s stress as it offers a temporary solution to a
difficult situation, rendering the surgeon a winner according
to Marty [4]. However, this technique in a great number of
patients may simply postpone the problem (possibly with
different clinical appearance) to the future. A more reliable
and also longer follow-up is needed in order to clarify if the
endovascular stenting is the real winner.References
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In the letter ‘Endovascular treatment of acute trau-
matic aortic rupture: radical solution or postponement of
the problem?’ Apostolakis et al. raise the question about
the superiority of the endovascular approach and its
durability [1]. Such discussion is to be encouraged when
another method, and especially one as revolutionary as
endovascular, is looking to replace a well established open
surgical treatment that has itself continuously improved for
half a century. However, the essence of the endovascular
repair of traumatic aortic rupture is about emergency
management of a life threatening injury in a severely
traumatized patient including a minimal (additional)
trauma load by the operation. Specifically, the medium-
and long-term issues related to the endovascular repair
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patient has recovered.
To date numerous studies including a recent review in
2007 [2] show a trend towards an improved outcome
following endovascular repair of traumatic aortic rupture
with a reduced procedure related mortality of 2% and overall
mortality of 6%. These results compare favorably to open
repair with an overall mortality of 12—26% and a 2—5% risk of
paraplegia inherent to the open technique. Pragmatism
speaks clearly in favor of the endovascular treatment. It is
ethically almost impossible to perform prospective rando-
mized trials. Nevertheless, there are also important risks
associated with the endovascular procedure, and the most
important one being the risk of a stroke resulting from
cerebral embolization. Others problems such as claudication
of the left arm can wait to be resolved later.
Although long-term results (five years and more) of the
endovascular repair are not yet known and may hamper the
enthusiasm of endovascular, late complications such as re-
expansion of the pseudoaneurysm due to endoleak, or
pseudocoarctation as a consequence of device collapse,
can be detected by a close follow-up and addressed
electively. Life threatening long-term complications such
as aorto-esophageal fistulas due to graft infection are rare
and may happen in the context of open repair as well. We
believe in endovascular as the overall winner for repair of
traumatic aortic rupture.
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The results of the 5-year follow-up of the MASS trial by
Lopes et al. [1] describing the ‘impact of number of diseased
vessels on clinical outcome’ was well written and read withgreat interest. It has again added fuel to the existing debate
of coronary artery bypass grafting (CABG) versus percuta-
neous intervention (PCI) with stenting versus medical
management in stable coronary artery disease and brings
out some important points for discussion.1. It is interesting to note that none of the randomized
controlled trials comparing CABG versus PCI with stent in
multivessel disease including the present one, have found
a superior advantage of CABG in survival over 5 years
[2,3]. Therefore it would be important to know if there
were any significant increases in ‘revascularization
procedures’ in the PCI with stent versus CABG arm
stratified by the number of vessel disease. The authors
have provided data comparing each treatment arm with
vessel involvement and comparing composite endpoints
of mortality, MI or refractory angina requiring revascular-
ization but not specifically for revascularization in the
same subgroup. [SVD — 10.7% with PCI vs 8.8% with CABG,
2VD — 14% revascularization with PCI vs 7.5% in CABG, 3VD
— 9.5% with PCI vs 8.9%with CABG, were these
significant?]. This would be important as increased
revascularization if observed in the PCI arm versus CABG
for a specific group (3VD or 2VD), would mean increased
health costs at same survival benefits.2. For reasons above and others it would be more
informative if the patient characteristics assigned to
treatment by CABG, PCI or medical had been provided for
each group. This would help to rule out selection bias.3. There was no increase in myocardial infarction (MI) in the
3VD group and the patients were significantly older. The
cause of death in these patients was probably due to
comorbid conditions and would be worth mentioning as it
would help us to target treatment towards these factors
in the face of better revascularization outcomes.4. The extent of aggressive lipid management in the
medically treatment group too is unclear. The COURAGE
[4] trial showed no benefit of PCI with aggressive medical
management over aggressive lipid management alone.
The LDL levels achieved in the medically treated patients
would help us compare the benefits of this treatment line
compared to CABG or PCI.5. We would like to point out an error in the units used for
cholesterol levels in these patients. They have been
mentioned as mmol/l but should be mg/dl.
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